Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2003, for Anthem, Inc. (now Elevance Health). Anthem is a major health benefits company and an independent licensee of the Blue Cross Blue Shield Association, operating in Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Maine, Colorado, Nevada, and Virginia. As of March 31, 2003, the company served approximately 11.5 million members. The reporting period includes the full impact of the July 2002 acquisition of Trigon Healthcare, Inc., which established the company's Southeast segment.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Total Operating Revenue | $4,015.9 million | $2,748.6 million |
| Net Income | $191.7 million | $99.8 million |
| Diluted Earnings Per Share | $1.36 | $0.95 |
| Operating Gain | $262.9 million | $106.6 million |
| Benefit Expense Ratio | 82.2% | 84.5% |
| Operating Margin | 6.5% | 3.9% |
| Cash and Cash Equivalents | $463.9 million | $456.3 million |
| Total Investments (Available-for-Sale) | $6,394.1 million | $5,948.1 million |
| Long-Term Debt | $1,660.3 million | $1,659.4 million |
| Debt-to-Total-Capital Ratio | 24.3% | 24.7% |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 46% to $4.02 billion, driven primarily by the inclusion of the Trigon acquisition (Southeast segment) and organic growth in premiums and administrative fees.
- Profitability: Net income surged 92% to $191.7 million. This was fueled by improved operating results across all health segments, higher investment income, and a significant non-recurring benefit from the resolution of the Dardinger litigation.
- Membership: Total membership grew 41% to 11.5 million. On a same-store basis (excluding Trigon), membership increased 10%, with notable gains in National Accounts, Local Large Group, and Individual businesses.
- Cost of Care: The aggregate cost of care trend was approximately 11% for the 12 months ended March 31, 2003. The benefit expense ratio improved by 230 basis points to 82.2%, aided by disciplined pricing and the litigation reserve release.
- Investments: Net realized gains on investments increased to $12.9 million (from $3.3 million), primarily due to the sale of fixed maturity securities to shorten portfolio duration.
Guidance, Outlook, and Risks
- Cost of Care Outlook: Management expects cost of care trends to range from 11% to 12% through the remainder of 2003. This is driven by professional services, outpatient services, and pharmacy costs.
- Acquisition Synergies: The company expects to achieve $40 million to $50 million in synergies from the Trigon acquisition in 2003, with at least $75 million by 2004. Approximately $10 million was captured in Q1 2003.
- Pending Acquisition: The acquisition of Blue Cross and Blue Shield of Kansas (BCBS-KS) for $190 million remains pending. The Kansas Supreme Court heard oral arguments in March 2003, but no ruling has been issued.
- Capital Allocation: The Board authorized a new $500 million stock repurchase program in January 2003. The company repurchased 1.6 million shares for $91 million in Q1 2003. A $1 billion commercial paper program was also established.
- Legal Contingencies: The company is involved in various class-action lawsuits regarding provider payments and coverage practices (e.g., MDL in Florida, Connecticut provider suits). While the Dardinger case was resolved with a $30 million judgment paid in Q1 2003, other litigation outcomes remain uncertain. The company also faces ongoing federal reviews regarding Medicare fiscal intermediary operations.
- Market Risks: Primary risks include interest rate fluctuations, credit risk, and market valuation risk affecting the investment portfolio, as well as regulatory changes and escalating healthcare costs.
Investor Verification Checklist
- Trigon Integration: Verify the realization of projected synergies ($40M-$50M in 2003) and the integration timeline for the Southeast segment.
- BCBS-KS Acquisition: Monitor the status of the Kansas Supreme Court ruling regarding the $190 million acquisition of BCBS-KS.
- Cost of Care Trends: Track actual medical cost trends against the 11-12% guidance, specifically monitoring pharmacy and professional services inflation.
- Legal Reserves: Assess the adequacy of reserves for ongoing provider class-action lawsuits and federal Medicare audits, given the volatility in managed care litigation.
- Investment Portfolio: Review the impact of interest rate changes on the $6.4 billion investment portfolio and the potential for other-than-temporary impairments.
- Stock Repurchases: Confirm the pace of the remaining $409 million authorized under the new stock repurchase program.